Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial von Perez, Edith A, Thompson, E Aubrey, Ballman, Karla V, Anderson, S Keith, Asmann, Yan W, Kalari, Krishna R, Eckel-Passow, Jeanette E, Dueck, Amylou C, Tenner, Kathleen S, Jen, Jin, Fan, Jian-Bing, Geiger, Xochiquetzal J, McCullough, Ann E, Chen, Beiyun, Jenkins, Robert B, Sledge, George W, Winer, Eric P, Gralow, Julie R, Reinholz, Monica M

Volltext

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K von Ma, Daniel J, Galanis, Evanthia, Anderson, S Keith, Schiff, David, Kaufmann, Timothy J, Peller, Patrick J, Giannini, Caterina, Brown, Paul D, Uhm, Joon H, McGraw, Steven, Jaeckle, Kurt A, Flynn, Patrick J, Ligon, Keith L, Buckner, Jan C, Sarkaria, Jann N

Volltext

Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer von HEEMERS, Hannelore V, SCHMIDT, Lucy J, ZHIFU SUN, REGAN, Kevin M, KEITH ANDERSON, S, DUNCAN, Kelly, DAN WANG, SONG LIU, BALLMAN, Karla V, TINDALL, Donald J

Volltext

Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models von Cen, Ling, Carlson, Brett L, Pokorny, Jenny L, Mladek, Ann C, Grogan, Patrick T, Schroeder, Mark A, Decker, Paul A, Anderson, S Keith, Giannini, Caterina, Wu, Wenting, Ballman, Karla V, Kitange, Gaspar J, Sarkaria, Jann N

Volltext

NI-36 VALIDATION OF RANO CRITERIA: CONTRIBUTION OF T2/FLAIR ASSESSMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB von Huang, Raymond, Rahman, Rifaquat, Pope, Whitney, Ellingson, Benjamin, Ballman, Karla, Felton, Sara, Anderson, SKeith, Nayak, Lakshmi, Lee, Eudocia, Abrey, Lauren, Galanis, Evanthia, Reardon, David, Cloughesy, Timothy, Wen, Patrick

Volltext

Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials von Lageman, Sarah K., Cerhan, Jane H., Locke, Dona E. C., Anderson, S. Keith, Wu, Wenting, Brown, Paul D.

Volltext

Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study von Aziz, David, Skeith, Leslie, Rodger, Marc A., Sabri, Elham, Righini, Marc, Kovacs, Michael J., Carrier, Marc, Kahn, Susan R., Wells, Philip S., Anderson, David R., Chagnon, Isabelle, Solymoss, Susan, Crowther, Mark A., White, Richard H., Le Gal, Grégoire

Volltext